Live feed
Filing
SC 13D
SC 13D0001601485-22-000030·Elicio Therapeutics, Inc.
Schedule 13D ownership disclosure
ANGION BIOMEDICA CORP
Security class unavailable · CUSIP: 03476J107
Event date: 2021-02-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001601485-22-000030
- Form type
- SC 13D
- Filer
- Elicio Therapeutics, Inc.
- CIK
- CIK 1601485
- Filed
- Apr 27, 2022
- Reporting period
- Feb 04, 2021
- Description
- Schedule 13D beneficial ownership